Alberta Investment Management Corp Bio Techne Corp Transaction History

Alberta Investment Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $1.51 Million - $2 Million	-22,344 Reduced 87.82%	3,100 $211,000
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $222,022 - $268,522	3,100 Added 13.87%	25,444 $1.89 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $1.33 Million - $5.82 Million	16,518 Added 283.52%	22,344 $1.85 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $1.9 Million - $2.64 Million	-5,878 Reduced 50.22%	5,826 $2.02 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $3.33 Million - $4.59 Million	9,404 Added 408.87%	11,704 $5.07 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $890,905 - $1.04 Million	2,300 New	2,300 $1.04 Million

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.42B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.